GOLETA, Calif. – Inogen has received 510(k) clearance from the U.S. Food and Drug Administration for the Simeox 200 Airway Clearance Device, expanding the company’s ability to market and meet the ...
Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid second-quarter 2024 ...
Recent Development for INGN In October, INGN announced that it had commenced the U.S. market release of the Inogen Rove 4 Portable Oxygen Concentrator. The Rove 4 utilizes Inogen’s patented ...
were students at UC Santa Barbara when they won a university competition with their idea for a portable oxygen concentrator. With her departure, all three founders of the Goleta-based medical device ...
StockNews.com cut shares of Inogen (NASDAQ:INGN – Free Report) from a buy rating to a hold rating in a research note published on Friday. Separately, Needham & Company LLC reaffirmed a “hold” rating ...